BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 25439769)

  • 1. Utility of mediastinoscopy in clinical stage I lung cancers at risk for occult mediastinal nodal metastases.
    Fernandez FG; Kozower BD; Crabtree TD; Force SD; Lau C; Pickens A; Krupnick AS; Veeramachaneni N; Patterson GA; Jones DR; Meyers BF
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):35-41, 42.e1. PubMed ID: 25439769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study.
    De Leyn P; Stroobants S; De Wever W; Lerut T; Coosemans W; Decker G; Nafteux P; Van Raemdonck D; Mortelmans L; Nackaerts K; Vansteenkiste J
    J Clin Oncol; 2006 Jul; 24(21):3333-9. PubMed ID: 16849747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Video-assisted thoracic surgery systematic mediastinal nodal dissection and stage migration: impact on clinical pathway.
    Amer K; Khan AZ; Singh N; Addis B; Jogai S; Harden S; Peebles C; Brown I
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1474-81. PubMed ID: 21497109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.
    Al-Sarraf N; Aziz R; Gately K; Lucey J; Wilson L; McGovern E; Young V
    Eur J Cardiothorac Surg; 2008 Jan; 33(1):104-9. PubMed ID: 17977738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?
    Sivrikoz CM; Ak I; Simsek FS; Döner E; Dündar E
    Thorac Cardiovasc Surg; 2012 Mar; 60(2):116-21. PubMed ID: 21692019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of extended cervical mediastinoscopy in staging of non-small cell lung cancer of the left lung and a comparison with integrated positron emission tomography and computed tomography: does integrated positron emission tomography and computed tomography reduce the need for invasive procedures?
    Metin M; Citak N; Sayar A; Pekcolaklar A; Melek H; Kök A; Gurses A
    J Thorac Oncol; 2011 Oct; 6(10):1713-9. PubMed ID: 21716145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study.
    Cerfolio RJ; Bryant AS; Eloubeidi MA
    Chest; 2006 Dec; 130(6):1791-5. PubMed ID: 17166998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT.
    Park HK; Jeon K; Koh WJ; Suh GY; Kim H; Kwon OJ; Chung MP; Lee KS; Shim YM; Han J; Um SW
    Respirology; 2010 Nov; 15(8):1179-84. PubMed ID: 20573058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
    Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive mediastinal staging for resected non-small cell lung cancer in a population-based cohort.
    Osarogiagbon RU; Lee YS; Faris NR; Ray MA; Ojeabulu PO; Smeltzer MP
    J Thorac Cardiovasc Surg; 2019 Oct; 158(4):1220-1229.e2. PubMed ID: 31147169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
    Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.
    Ghaly G; Rahouma M; Kamel MK; Nasar A; Harrison S; Nguyen AB; Port J; Stiles BM; Altorki NK; Lee PC
    Ann Thorac Surg; 2017 Oct; 104(4):1153-1158. PubMed ID: 28551047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients.
    Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
    J Thorac Oncol; 2012 Aug; 7(8):1246-51. PubMed ID: 22659962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.
    Meyers BF; Haddad F; Siegel BA; Zoole JB; Battafarano RJ; Veeramachaneni N; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling.
    McLoud TC; Bourgouin PM; Greenberg RW; Kosiuk JP; Templeton PA; Shepard JA; Moore EH; Wain JC; Mathisen DJ; Grillo HC
    Radiology; 1992 Feb; 182(2):319-23. PubMed ID: 1732943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
    Darling GE; Maziak DE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Gu CS; Kuruvilla MS; Cline KJ; Julian JA; Evans WK; Levine MN
    J Thorac Oncol; 2011 Aug; 6(8):1367-72. PubMed ID: 21587082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated positron-emission tomography for nodal staging in lung cancer.
    Lee HJ; Kim YT; Kang WJ; Lee HJ; Kang CH; Kim JH
    Asian Cardiovasc Thorac Ann; 2009 Dec; 17(6):622-6. PubMed ID: 20026540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended cervical mediastinoscopy: mature results of a clinical protocol for staging bronchogenic carcinoma of the left lung.
    Obiols C; Call S; Rami-Porta R; Iglesias M; Saumench R; Serra-Mitjans M; Gonzalez-Pont G; Belda J
    Eur J Cardiothorac Surg; 2012 May; 41(5):1043-6. PubMed ID: 22219461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of positron emission tomography-computed tomography in identification of mediastinal lymph node status in patients with non-small cell lung cancer.
    Sanli M; Isik AF; Zincirkeser S; Elbek O; Mete A; Tuncozgur B; Elbeyli L
    J Thorac Cardiovasc Surg; 2009 Nov; 138(5):1200-5. PubMed ID: 19660381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.